195 related articles for article (PubMed ID: 28410293)
1. Long-term Efficacy of Methotrexate Plus Vinblastine/Vinorelbine in a Large Series of Patients Affected by Desmoid-Type Fibromatosis.
Palassini E; Frezza AM; Mariani L; Lalli L; Colombo C; Fiore M; Messina A; Casale A; Morosi C; Collini P; Stacchiotti S; Casali PG; Gronchi A
Cancer J; 2017; 23(2):86-91. PubMed ID: 28410293
[TBL] [Abstract][Full Text] [Related]
2. [Low-dose methotrexate combined with vinorelbine for inoperable desmoid tumor: efficacy and the prognostic factors].
Fan Z; Li S; Fang Z; Liu J; Bai C; Xue R; Zhang L; Gao T
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jan; 36(1):39-43. PubMed ID: 26806736
[TBL] [Abstract][Full Text] [Related]
3. Therapy of desmoid tumors and fibromatosis using vinorelbine.
Weiss AJ; Horowitz S; Lackman RD
Am J Clin Oncol; 1999 Apr; 22(2):193-5. PubMed ID: 10199460
[TBL] [Abstract][Full Text] [Related]
4. Clinical benefit of methotrexate plus vinorelbine chemotherapy for desmoid fibromatosis (DF) and correlation of treatment response with MRI.
Ingley KM; Burtenshaw SM; Theobalds NC; White LM; Blackstein ME; Gladdy RA; Thipphavong S; Gupta AA
Cancer Med; 2019 Sep; 8(11):5047-5057. PubMed ID: 31301110
[TBL] [Abstract][Full Text] [Related]
5. Oral vinorelbine in young patients with desmoid-type fibromatosis.
Kornreich L; Orbach D; Nicolas N; Brisse HJ; Berlanga P; Defachelles AS; Mansuy L; Verite C; Saumet L; Karanian M; Corradini N
Tumori; 2023 Oct; 109(5):511-518. PubMed ID: 37114926
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging patterns of tumor response to chemotherapy in desmoid-type fibromatosis.
Zanchetta E; Ciniselli CM; Bardelli A; Colombo C; Stacchiotti S; Baldi GG; Provenzano S; Bertulli R; Bini F; Casale A; Greco FG; Ferrari A; Verderio P; Fiore M; Gronchi A; Casali PG; Morosi C; Palassini E
Cancer Med; 2021 Jul; 10(13):4356-4365. PubMed ID: 34102009
[TBL] [Abstract][Full Text] [Related]
7. Pazopanib or methotrexate-vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study.
Toulmonde M; Pulido M; Ray-Coquard I; Andre T; Isambert N; Chevreau C; Penel N; Bompas E; Saada E; Bertucci F; Lebbe C; Le Cesne A; Soulie P; Piperno-Neumann S; Sweet S; Cecchi F; Hembrough T; Bellera C; Kind M; Crombe A; Lucchesi C; Le Loarer F; Blay JY; Italiano A
Lancet Oncol; 2019 Sep; 20(9):1263-1272. PubMed ID: 31331699
[TBL] [Abstract][Full Text] [Related]
8. Combination chemotherapy using vinblastine and methotrexate for the treatment of progressive desmoid tumor in children.
Skapek SX; Hawk BJ; Hoffer FA; Dahl GV; Granowetter L; Gebhardt MC; Ferguson WS; Grier HE
J Clin Oncol; 1998 Sep; 16(9):3021-7. PubMed ID: 9738571
[TBL] [Abstract][Full Text] [Related]
9. Desmoid with biweekly methotrexate and vinblastine shows similar effects to weekly administration: A phase II clinical trial.
Nishida Y; Hamada S; Urakawa H; Ikuta K; Sakai T; Koike H; Ito K; Emoto R; Ando Y; Matsui S
Cancer Sci; 2020 Nov; 111(11):4187-4194. PubMed ID: 32816351
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of low-dose chemotherapy with methotrexate and vinblastine for patients with extra-abdominal desmoid-type fibromatosis: a systematic review.
Shimizu K; Hamada S; Sakai T; Koike H; Yoshida M; Nishida Y
Jpn J Clin Oncol; 2020 Apr; 50(4):419-424. PubMed ID: 31845730
[TBL] [Abstract][Full Text] [Related]
11. Vinblastine and methotrexate for desmoid fibromatosis in children: results of a Pediatric Oncology Group Phase II Trial.
Skapek SX; Ferguson WS; Granowetter L; Devidas M; Perez-Atayde AR; Dehner LP; Hoffer FA; Speights R; Gebhardt MC; Dahl GV; Grier HE;
J Clin Oncol; 2007 Feb; 25(5):501-6. PubMed ID: 17290057
[TBL] [Abstract][Full Text] [Related]
12. Advanced aggressive fibromatosis: Effective palliation with chemotherapy.
Constantinidou A; Jones RL; Scurr M; Al-Muderis O; Judson I
Acta Oncol; 2011 Apr; 50(3):455-61. PubMed ID: 20799916
[TBL] [Abstract][Full Text] [Related]
13. Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis.
Azzarelli A; Gronchi A; Bertulli R; Tesoro JD; Baratti D; Pennacchioli E; Dileo P; Rasponi A; Ferrari A; Pilotti S; Casali PG
Cancer; 2001 Sep; 92(5):1259-64. PubMed ID: 11571741
[TBL] [Abstract][Full Text] [Related]
14. Familial adenomatosis polyposis-related desmoid tumours treated with low-dose chemotherapy: results from an international, multi-institutional, retrospective analysis.
Napolitano A; Provenzano S; Colombo C; Vitellaro M; Brunello A; Badalamenti G; Nannini M; Ibrahim T; Hohenberger P; Gasperoni S; Gennatas S; Jones RL; Hindi N; Martin-Broto J; Spalato Ceruso M; Silletta M; Dei Tos AP; Gronchi A; Stacchiotti S; Santini D; Tonini G; Palassini E; Vincenzi B
ESMO Open; 2020 Jan; 5(1):. PubMed ID: 31958289
[TBL] [Abstract][Full Text] [Related]
15. Combination chemotherapy in adult desmoid tumors.
Patel SR; Evans HL; Benjamin RS
Cancer; 1993 Dec; 72(11):3244-7. PubMed ID: 8242548
[TBL] [Abstract][Full Text] [Related]
16. Combination chemotherapy with methotrexate and vinblastine for surgically unresectable, aggressive fibromatosis.
Park KH; Choi YJ; Kim KW; Ro KH; Kang CH; Song SH; Park JH
Jpn J Clin Oncol; 2016 Sep; 46(9):845-9. PubMed ID: 27365524
[TBL] [Abstract][Full Text] [Related]
17. Aggressive fibromatosis in children and adolescents: the Italian experience.
Meazza C; Bisogno G; Gronchi A; Fiore M; Cecchetto G; Alaggio R; Milano GM; Casanova M; Carli M; Ferrari A
Cancer; 2010 Jan; 116(1):233-40. PubMed ID: 19950127
[TBL] [Abstract][Full Text] [Related]
18. Effective treatment of multifocal aggressive fibromatosis with low-dose chemotherapy.
Caglar K; Ozyönüm H; Akalin M; Balci S
Turk J Pediatr; 2006; 48(4):365-8. PubMed ID: 17290575
[TBL] [Abstract][Full Text] [Related]
19. Low-dose chemotherapy with vinblastine and methotrexate in childhood desmoid tumors.
Reich S; Overberg-Schmidt US; Bührer C; Henze G
J Clin Oncol; 1999 Mar; 17(3):1086. PubMed ID: 10071306
[No Abstract] [Full Text] [Related]
20. Low-dose chemotherapy with methotrexate and vinblastine for patients with desmoid tumors: relationship to CTNNB1 mutation status.
Nishida Y; Tsukushi S; Urakawa H; Hamada S; Kozawa E; Ikuta K; Ando Y; Ishiguro N
Int J Clin Oncol; 2015 Dec; 20(6):1211-7. PubMed ID: 25899770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
